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Abstract
Atopic diseases, such as atopic dermatitis (AD) and asthma, are closely related to clinical phenotypes with hypersensitivity,
and often share some similar genetic and pathogenic bases. Our recent GWAS identified three susceptibility gene/loci FLG
(rs11204971 and rs3126085), 5q22.1 (rs10067777, rs7701890, rs13360927 and rs13361382) and 20q13.33 (rs6010620) to AD.
The effect of these AD associated polymorphisms in asthma is so far unknown. To investigate whether AD relevant genetic
variants is identical to asthma and reveal the differences in genetic factors between AD and asthma in Chinese Han
population, seven AD associated single nucleotide polymorphisms (SNPs) as well as 3 other SNPs (rs7936562 and rs7124842
at 11q13.5 and rs4982958 at 14q11.2) from our previous AD GWAS were genotyped in 463 asthma patients and 985 controls
using Sequenom MassArray system. We found rs4982958 at 14q11.2 was significantly associated with asthma
(P=3.04610
24, OR=0.73). We also detected one significant risk haplotype GGGA from the 4 SNPs (rs10067777,
rs7701890, rs13360927 and rs13361382) at 5q22.1 in AD cases (Pcorrection=3.60610
210, OR=1.26), and the haplotype was
suggestive of risk in asthma cases in this study (P=0.014, Pcorrection=0.084, OR=1.38). These SNPs (rs11204971, rs3126085,
rs7936562, rs712484 and rs6010620) at AD susceptibility genes/loci FLG, 11q13.5 and 20q13.33 were not associated with
asthma in this study. Our results further comfirmed that 14q11.2 was an important candidate locus for asthma and
demonstrated that 5q22.1 might be shared by AD and asthma in Chinese Han population.
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Introduction
Atopic diseases, such as atopic dermatitis (AD), asthma and
allergic rhinitis (AR), are closely related to clinical phenotypes that
are often observed with hypersensitivity. The mechanisms leading
to atopic diseases development remain yet unknown. It is supposed
that the cases would attribute to the interacted effect of multiple
genetic variations and environmental factors on their pathophys-
iology. Asthma is documented being associated with atopic
dermatitis [1]. Approximately half of AD patients, particularly in
the severe AD, will develop into asthma [2].
Previous linkage study, candidate gene and GWAS have identified
several susceptibility loci/genes predisposing to AD and asthma.
Some common genetic factors such as FLG, ADAM33,a n dGSDML/
ORMDL3 h a db e e no b s e r v e di np a t i e n t sw i t hA Da n da s t h m a[ 3 ] .
Other genetic investigations illuminated several important candidate
genes in Chromosome 14q11.2, whichcould contribute to the genetic
predisposition to specific allergic reactions characterized by asthma
and high level of serum IgE [4,5]. In one previous GWAS of AD in
the European populations, 11q13.5 (C11orf30) was highlighted as a
susceptibility locus of AD [6], which was also pointed to contain a
concurrent involvement of the common genetic factors for AD and
asthma [7]. In one recent AD GWAS, we identified two novel
susceptibility loci 5q22.1 (rs10067777, rs7701890, rs13360927 and
rs13361382), 20q13.33 (rs6010620) and confirmed susceptibility gene
FLG (rs11204971 and rs3126085) of AD [8]. The genetic effect of
these AD associated factors in asthma is unknown.
In this study, we further analyze the 7 SNPs described above at
FLG, 5q22.1, 20q13.33, as well as 3 other SNPs (rs7936562 and
rs7124842 at 11q13.5, rs4982958 at 14q11.2) to identify genetic
variants for asthma and reveal the common and different genetic
factors for AD and asthma in the Chinese Han population.
Methods
Subjects
A total of 463 patients with asthma and 985 controls were
enrolled in this study (Table 1). All samples were unrelated and
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No. 1 Hospital of Anhui Medical University in China according to
the American Thoracic Society (ATS) guidelines [9]: First, the
presence of at least two of the following symptoms was examined:
recurrent cough, wheezing or dyspnea. Second, we examined for
increased airway responsiveness to methacholine or the presence
of reversible airflow limitation; the latter refers to 15% variability
in the forced expiratory volume in 1 second (FEV1), or in the peak
expiratory flow rate with or without an inhaled short-acting b2-
agonist. Third, there was the absence of any other pulmonary
diseases. Clinical information was collected from the affected
individuals through a full clinical checkup by physician specialists.
Additional demographic information was collected from both
cases and controls through a structured questionnaire. All controls
were clinically assessed to be without asthma, other atopic diseases,
family history of atopic diseases (including first-, second- and third-
degree relatives) or systemic disorders. The study was approved by
the Institutional Ethics Committee of Anhui Medical University
and was conducted according to Declaration of Helsinki
principles. Collection of blood samples and clinical information
from cases and controls was undertaken after written informed
consent was obtained from all participants. DNA was extracted
from peripheral blood lymphocytes using QIAamp DNA Blood kit
(Qiagen, Valencia, CA, USA) according to the manufacturer’s
instructions. The extracted genomic DNAs were analyzed by
agarose gel electrophoresis, quantified by spectrophotometer, and
stored at 280uC until used.
SNP selection and genotyping
We selected 10 SNPs based on our previous AD GWAS and
genotyped them in 463 asthma patients. Seven of the 10 SNPs
were associated with AD (rs11204971 and rs3126085 in FLG,
rs10067777, rs7701890, rs13360927 and rs13361382 at 5q22.1,
and rs6010620 at 20q13.33). Additional 2 top SNPs within
11q13.5 (rs7936562 and rs7124842) and one top SNP within
14q11.2 (rs4982958) in discovery samples of our AD GWAS were
also selected. The annotated nominal gene was taken from the
Illumina SNP database. SNPs were genotyped using the
Sequenom MassArray system at State Key Laboratory Incubation
Base of Dermatology, Ministry of National Science and Technol-
ogy, Hefei, Anhui, China. Approximately 15 ng of genomic DNA
was used to genotype each sample. Locus-specific PCR and
detection primers were designed using the MassARRAY Assay
Design 3.0 software (Sequenom). The DNA samples were
amplified by multiplex PCR reactions, and the PCR products
were then used for locus-specific single-base extension reactions.
The resulting products were desalted and transferred to a 384-
element SpectroCHIP array. Allele detection was performed using
MALDI-TOF MS. The mass spectrograms were analyzed by the
MassARRAY Typer software (Sequenom).
Statistical analysis
The SNPs were analyzed for association with the disease by
means of comparison of the minor allele frequency in the cases
and the controls using PLINK 1.07 software [10]. The level of
associated significance was assigned at P values of less than 0.005
after Bonferroni Multiple Testing correction for asthma case-
control analysis, and less than 5.0610
28 for AD GWAS. In
addition to the allelic test of association, the genetic models
(dominant model, recessive model and additive model) were
calculated for the associated SNPs. For the SNPs at 5q22.1
(TMEM232/SLC25A46), haplotype analyses were performed to
calculate haplotype frequencies and significance of associations for
asthma case-control study by using Haploview v4.2 [11]. The
extent of genetic heterogeneity was assessed by using Cochran’s Q
test and the I
2 index [12] between AD and asthma groups. All the
SNPs passed the quality control in terms of with a call rate .95%,
Hardy–Weinberg equilibrium (HWE) (P.0.01) in the controls.
The genetic statistical power for all genotyped SNPs was estimated
using CaTS-Power Calculator software [13].
Results
SNP rs4982958 at 14q11.2 was significantly associated with
asthma in this study (P=3.04610
24, OR=0.73). Risk allele C of
the SNP rs4982958 represented the major allele and allele T was
protective one in Chinese Han population for asthma (Table 2).
The genotype TT appeared significantly less frequent in asthma
cases (5.5%) than in controls (12.9%), higher frequency of the
genotype CC was observed in cases (46.1%) than in controls
(39.8%). The difference in distribution of rs4982958 genotype
between the asthma cases and controls was statistically significant
(P=5.96610
25) (Table 3). Those SNPs locating within AD
susceptibility gene/loci FLG, 5q22.1, 11q13.5 and 20q13.33 did
not reach the threshold significant association for asthma
(P.0.005, after Bonferroni Multiple Testing correction)
(Table 2). For the SNPs in FLG (rs11204971 and rs3126085)
and 14q11.2 (rs4982958), we found significant evidence for genetic
heterogeneity between AD and asthma groups in this study
(Phet#0.0031, I
2$88.6) (Table 2).
Six haplotypes in combination with the 4 SNPs (rs10067777,
rs7701890, rs13360927 and rs13361382) were established at
5q22.1 in asthma samples, and 3 haplotypes in AD samples.
The integrated haplotype GGGA showed a significant association
with AD (Pcorrection=3.60610
210, OR=1.26) and weakly signif-
icant in asthma cases and controls (P=0.014, OR=1.38) (Table 4),
which had no genetic heterogeneity between AD and asthma
(Phet=0.590, I
2=0). After Bonferroni Multiple Testing corre-
ction, haplotype GGGA was no more significant for asthma
(Pcorrection=0.084) (Table 4).
Discussion
AD and asthma are complex genetic diseases, which would
result from integrated effect of multiple genetic and environmental
factors on pathophysiology process of the entities. Some common
genetic factors being shared in the patients with AD and asthma
have been identified [3]. Here we investigated the association of 10
SNPs within FLG, 5q22.1, 11q13.5, 14q11.2 and 20q13.33 for
asthma in the Chinese Han population, to evaluate the
relationship between AD and asthma in these loci/genes.
Table 1. Summary information of asthma patients and health
controls.
Cases Controls
Total number 463 985
Age(years) 9.7668.52 25.83611.83
Male (%) 273(59.0%) 560(56.9%)
Female (%) 190(41.0%) 425(43.1%)
with AD 49(10.6%) NA
with AR 153(33.0%) NA
NA=Not available.
doi:10.1371/journal.pone.0035334.t001
SNPs Association Analysis in AD and Asthma
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CMA1, CTSG and GZMH were located within a single 220 kb LD
block surrounding the tag biomarker rs4982958 which was
associated with asthma in this study (Figure 1a). Previous studies
selected mast cell chymase gene (CMA1) at 14q11.2 as a candidate
gene for analysis of AD, asthma and other allergic phenotypes
[14]. Mast cell tryptase and chymase are key players in mediating
chronic inflammation, as observed in asthmatics of the lungs. Two
polymorphisms in CMA1, including promoter polymorphism
rs1800875 (21903G/A) [15–18] and (TG)n(GA)m repeat poly-
morphism [19–21], were identified being associated with the
allergic phenotypes in different populations. However, other
studies failed to replicate role of 21903G/A (rs1800875) in AD
or asthma [18,22–24]. Inconsistence in these studies probably was
attributable to different populations, variation on phenotype
definitions, ethnicity and environmental exposure.
We observed that the association of rs4982958 with asthma
under additive model (P=1.75610
25) was of more significance
than that under dominant model (P=2.50610
22) and recessive
model (P=3.05610
25) by using a logistic regression analysis
(Table 3). Clearly, risk allele C of rs4982958 was the major one
and allele T was of protection effect. Compared with C/C, the
genotype of homozygote T/T (ORHom=0.37) showed smaller
OR than the heterozygote T/C (ORHet=0.89) (Table 3). This
result may provide more information for futher study on this locus.
Rs4982958 located at 10.4 kb upstream of CMA1. Linkage
disequilibrium (LD) test showed that the two SNPs (rs4982958
and rs1800875) were moderately correlated with each other
(D’=1.0, r
2=0.5) in CHB and JPT from 1000 Genomes Project
data. Imputation of promoter polymorphism rs1800875 of CMA1
was performed in our AD GWAS samples and then tested for
association (P=1.11610
22, OR=0.85). In AD GWAS,
Table 2. Summary of association results of 10 SNPs in five loci/genes and heterogeneity test between AD and asthma groups.
SNP Chr Gene Allele
a
Association evidence
in AD GWAS Association result in Asthma Heterogeneity test
MAF
b
P
c OR (95% CI)
Statistical
power Phet
d I
2(%)
e
Cases Controls
rs11204971 1q21.3 FLG A/G susceptibility gene 0.4556 0.4220 8.96E202 1.15 (0.98–1.34) 15% 0.0008 91.18
rs3126085 1q21.3 G/A 0.4446 0.4202 2.18E201 1.10 (0.94–1.29) 6% 0.0014 90.25
rs7701890 5q22.1 TMEM232/SLC25A46 G/A susceptibility loci 0.1296 0.1249 7.22E201 1.04 (0.83–1.32) 1% 0.2763 15.62
rs10067777 5q22.1 G/A 0.1231 0.1133 4.45E201 1.10 (0.86–1.40) 2% 0.5265 0
rs13360927 5q22.1 G/A 0.1247 0.1233 9.15E201 1.01 (0.80–1.29) 1% 0.2313 30.20
rs13361382 5q22.1 A/G 0.1278 0.1214 6.42E201 1.06 (0.83–1.36) 1% 0.4284 0
rs7124842 11q13.5 C11orf30 A/G susceptibility gene 0.2516 0.2813 9.62E202 0.86 (0.72–1.03) 13% 0.4422 0
rs7936562 11q13.5 A/G 0.4143 0.4354 2.87E201 0.92 (0.78–1.08) 4% 0.9393 0
rs4982958 14q11.2 CMA1 T/C no evidence 0.2969 0.3656 3.04E204 0.73 (0.62–0.87) 78% 0.0031 88.60
rs6010620 20q13.33 TNFRSF6B/ZGPA G/A susceptibility loci 0.2613 0.2585 8.74E201 1.02 (0.85–1.21) 1% 0.1369 54.81
aMinor allele/major allele.
bMAF, minor allele frequency.
cTwo tail test P value.
dPhet: P value of Cochran’s Q test between AD group and asthma group.
eThe I
2 index describes the proportion of the total variability that is due to heterogeneity as described in reference 12.
doi:10.1371/journal.pone.0035334.t002
Table 3. Distribution of genotypes and genetic model analysis for rs4982958 in asthma patients and controls.
Cases(n=458) Controls(n=982) OR (95% CI) P
Genotype
CC 211(46.1%) 391(39.8%) Reference 5.69E205
a
TT 25(5.5%) 127(12.9%) 0.37(0.23–0.58)
TC 222(48.4%) 464(47.3%) 0.89(0.70–1.12)
Recessive model
TT/(TC+CC) 25(5.5%)/433(94.5%) 127(12.9%)/855(87.1%) 0.39(0.25–0.61) 3.05E205
Dominant model
(TT+TC)/CC 247(53.9%)/211(46.1%) 591(60.2%)/391(39.8%) 0.77(0.62–0.97) 2.50E202
Additive model
TT/TC/CC 25(5.5%)/222(48.4%)/211(46.1%) 127(12.9%)/464(47.3%)/391(39.8%) 0.60(0.48–0.76) 1.75E205
T:Minor allele(effect allele), C:Major allele(reference allele).
aPatients vs controls using 263 contingency table.
doi:10.1371/journal.pone.0035334.t003
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found a weak evidence of association in the Chinese Han
population (P=1.22610
22, OR=0.94), but did not reach
genome-wide significance (P,5.0610
28) [8]. Statistical tests
showed that the odds ratio of rs4982958 in asthma samples
(OR=0.73) was smaller than in AD (OR=0.94) and the existence
of significant genetic heterogeneity between AD and asthma
(Phet=0.0031, I
2=88.60) in Chinese Han population.
Our AD GWAS had identified 5q22.1 as a susceptibility locus
for AD [8]. In this study, further haplotype analysis of the 4 SNPs
(rs10067777, rs7701890, rs13360927 and rs13361382) within
5q22.1 was performed in AD and asthma groups, respectively.
Only two haplotypes (AAAG and GGGA) had allele frequencies
.5% (Table 4). The risk haplotype GGGA had a consistent
association evidence for AD (Pcorrection=3.60610
210, OR=1.26)
as single SNP did (Table 4). It further supported the presence of
underlying causal variants within this locus for AD. None of the 4
SNPs within 5q22.1 was associated with asthma in such a small
samples size and low statistical power (1%,2%) in this study. The
risk allele of these SNPs at this locus was the same for AD and
asthma. In asthma group, haplotype GGGA was a suggestive risk
factor in this study (P=0.014), although it was barely below
significance (P=0.084) after multiple testing correction. We
observed that the odds ratio of haplotype GGGA (OR=1.38)
was much higher than single SNP in asthma cases-controls
samples (1.04#OR#1.10). Further more, heterogeneity test at
5q22.1 showed that no genetic heterogeneity was found for each
SNPs (0.2313#Phet#0.5265, 0#I
2#30.2) (Table 2) and risk
haplotype GGGA (Phet=0.590, I
2=0) (Table 4) between AD
and asthma groups, which means 5q22.1 might have similar effect
on AD and asthma. The four SNPs (rs10067777, rs7701890,
rs13360927 and rs13361382) located within a 600 kb LD block
harboring two genes TMEM232 (FLJ43080) and SLC25A46. Little
is known about the function of the two genes. At 5q22.1, TSLP and
Table 4. Haplotype analysis of 4 SNPs within 5q22.1 in AD/asthma patients and controls.
Haplotype Asthma cases-controls AD cases-controls
Heterogeneity
test
F_A F_U OR (95%CI) PP correction
a F_A F_U OR (95%CI) PP correction
a Phet
b I
2(%)
c
AAAG 0.859 0.837 1.21(0.94–1.46) 0.126 0.756 0.837 0.864 0.90(0.85–0.96) 1.85610
23 5.55610
23 0.089 65.35
GGGA 0.114 0.086 1.38(1.07–1.78) 0.014 0.084 0.139 0.093 1.26(1.17–1.35) 1.20610
210 3.60610
210 0.590 0
AGGA 0.001 0.023 0.05(0.01–0.33) 1.08610
25 6.48610
25 N/A N/A N/A N/A N/A N/A N/A
GAAG 0.003 0.024 0.13(0.04–0.43) 4.70610
25 2.82610
24 N/A N/A N/A N/A N/A N/A N/A
AGAG 0.008 0.014 0.63(0.28–1.38) 0.198 1 N/A N/A N/A N/A N/A N/A N/A
AAGA 0.008 0.012 0.64(0.27–1.50) 0.329 1 0.009 0.018 0.86(0.68–1.10) 0.213 0.639 0.085 66.29
aPcorrection: P value after Bonferroni Multiple Testing correction.
bPhet: P value of Cochran’s Q test between AD group and asthma group.
cThe I
2 index describes the proportion of the total variability that is due to heterogeneity as described in reference 12.
doi:10.1371/journal.pone.0035334.t004
Figure 1. Regional LD plots for associated SNPs. The r
2 values (y-axis) of SNPs were plotted against their map positions (x-axis). Estimated
recombination rates (based on the combined CHB and JPT samples from the HapMap project) were plotted in light blue. Gene annotations were
adapted from the University of California at Santa Cruz Genome Browser (http://genome.ucsc.edu/). (a): Regional LD plots for rs4982958 at 14q11.2.
(b): Regional LD plots for rs10067777, rs7701890, rs13360927 and rs13361382 at 5q22.1.
doi:10.1371/journal.pone.0035334.g001
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Caucasian population [25–27]. Nevertheless, we found haplotype
GGGA fall into different LD blocks with TSLP and WDR36,
which were separated by a recombination hot spot (Figure 1b).
Fine-mapping or direct sequencing would be powerful to further
search for any potential and associated susceptibility genes at
5q22.1 dedicated to both AD and asthma.
The 5 SNPs in FLG, 11q13.5 and 20q13.33 did not reached the
statistical significance in this study, which might either result from
low statistical power (1%,15%) (Table 2) or be attributed to
10.6% of these asthma cases with previous history of AD (Table 1).
Comprehensive sequencing of entire FLG in asthma patients and
larger scale of asthma samples or increased related tagSNPs for
11q13.5 and 20q13.33 would reliably enable to explore the
relationship between AD and asthma in these loci/gene.
In conclusion, we compared the identical SNPs from the asthma
cohort and our previous AD GWAS. We comfirmed 14q11.2 was
an important candidate locus for asthma, and also demonstrated
that 5q22.1 might be shared by AD and asthma in Chinese Han
population. However, the evidences for the associations will be
required to validate in diverse populations and then gain a better
understanding on AD and asthma pathogenesis.
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